Drug Shortage Report for MIDAZOLAM INJECTION
| Report ID | 123744 |
| Drug Identification Number | 02423766 |
| Brand name | MIDAZOLAM INJECTION |
| Common or Proper name | MIDAZOLAM |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | MIDAZOLAM |
| Strength(s) | 5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS |
| Packaging size | 10 x 1ML VIALS |
| ATC code | N05CD |
| ATC description | HYPNOTICS AND SEDATIVES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2020-09-25 |
| Actual start date | |
| Estimated end date | |
| Actual end date | 2020-10-07 |
| Shortage status | Resolved |
| Updated date | 2020-10-08 |
| Company comments | Item has been discontinued. |
| Health Canada comments | |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.